RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Yasuhiro Yamauchi to Middle Aged

This is a "connection" page, showing publications Yasuhiro Yamauchi has written about Middle Aged.
Connection Strength

0.626
  1. Hiraishi Y, Jo T, Michihata N, Hasegawa W, Sakamoto Y, Urushiyama H, Matsui H, Fushimi K, Nagase T, Yasunaga H, Yamauchi Y. Hospital Volume and Mortality following Diagnostic Bronchoscopy in Lung Cancer Patients: Data from a National Inpatient Database in Japan. Respiration. 2019; 97(3):264-272.
    View in: PubMed
    Score: 0.060
  2. Urushiyama H, Jo T, Yasunaga H, Michihata N, Matsui H, Hasegawa W, Takeshima H, Sakamoto Y, Hiraishi Y, Mitani A, Fushimi K, Nagase T, Yamauchi Y. Oral fluorouracil vs vinorelbine plus cisplatin as adjuvant chemotherapy for stage II-IIIA non-small cell lung cancer: Propensity score-matched and instrumental variable analyses. Cancer Med. 2018 10; 7(10):4863-4869.
    View in: PubMed
    Score: 0.059
  3. Jo T, Yasunaga H, Michihata N, Sasabuchi Y, Hasegawa W, Takeshima H, Sakamoto Y, Matsui H, Fushimi K, Nagase T, Yamauchi Y. Influence of Parkinsonism on outcomes of elderly pneumonia patients. Parkinsonism Relat Disord. 2018 09; 54:25-29.
    View in: PubMed
    Score: 0.058
  4. Yamauchi Y, Yasunaga H, Sakamoto Y, Hasegawa W, Takeshima H, Urushiyama H, Jo T, Matsui H, Fushimi K, Nagase T. Mortality associated with bone fractures in COPD patients. Int J Chron Obstruct Pulmon Dis. 2016; 11:2335-2340.
    View in: PubMed
    Score: 0.052
  5. Yamauchi Y, Yasunaga H, Hasegawa W, Sakamoto Y, Takeshima H, Jo T, Matsui H, Fushimi K, Nagase T. Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016; 11:1403-11.
    View in: PubMed
    Score: 0.051
  6. Yamauchi Y, Yasunaga H, Matsui H, Hasegawa W, Jo T, Takami K, Fushimi K, Nagase T. Comparison of clinical characteristics and outcomes between aspiration pneumonia and community-acquired pneumonia in patients with chronic obstructive pulmonary disease. BMC Pulm Med. 2015 Jul 08; 15:69.
    View in: PubMed
    Score: 0.048
  7. Yamauchi Y, Yasunaga H, Matsui H, Hasegawa W, Jo T, Takami K, Fushimi K, Nagase T. Comparison of in-hospital mortality in patients with COPD, asthma and asthma-COPD overlap exacerbations. Respirology. 2015 Aug; 20(6):940-6.
    View in: PubMed
    Score: 0.047
  8. Yamauchi Y, Kohyama T, Jo T, Nagase T. Dynamic change in respiratory resistance during inspiratory and expiratory phases of tidal breathing in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2012; 7:259-69.
    View in: PubMed
    Score: 0.038
  9. Yamauchi Y, Yoshizawa A, Kudo K, Okuwaki H, Niino H, Morita T. [A case of lymphomatoid granulomatosis with multiple thin-walled cavities]. Nihon Kokyuki Gakkai Zasshi. 2002 Apr; 40(4):292-8.
    View in: PubMed
    Score: 0.019
  10. Sakamoto Y, Yamauchi Y, Jo T, Michihata N, Hasegawa W, Takeshima H, Matsui H, Fushimi K, Yasunaga H, Nagase T. In-hospital mortality associated with community-acquired pneumonia due to methicillin-resistant Staphylococcus aureus: a matched-pair cohort study. BMC Pulm Med. 2021 Nov 03; 21(1):345.
    View in: PubMed
    Score: 0.018
  11. Tamiya H, Mitani A, Saito A, Ishimori T, Saito M, Isago H, Jo T, Yamauchi Y, Tanaka G, Nagase T. Exosomal MicroRNA Expression Profiling in Patients with Lung Adenocarcinoma-associated Malignant Pleural Effusion. Anticancer Res. 2018 Dec; 38(12):6707-6714.
    View in: PubMed
    Score: 0.015
  12. Mitani A, Jo T, Yasunaga H, Sakamoto Y, Hasegawa W, Urushiyama H, Yamauchi Y, Matsui H, Fushimi K, Nagase T. Venous thromboembolic events in patients with lung cancer treated with cisplatin-based versus carboplatin/nedaplatin-based chemotherapy. Anticancer Drugs. 2018 07; 29(6):560-564.
    View in: PubMed
    Score: 0.015
  13. Jo T, Yasunaga H, Sasabuchi Y, Michihata N, Morita K, Yamauchi Y, Hasegawa W, Takeshima H, Sakamoto Y, Matsui H, Fushimi K, Nagase T. Association between dementia and discharge status in patients hospitalized with pneumonia. BMC Pulm Med. 2017 Oct 06; 17(1):128.
    View in: PubMed
    Score: 0.014
  14. Shinno Y, Kage H, Chino H, Inaba A, Arakawa S, Noguchi S, Amano Y, Yamauchi Y, Tanaka G, Nagase T. Old age and underlying interstitial abnormalities are risk factors for development of ARDS after pleurodesis using limited amount of large particle size talc. Respirology. 2018 01; 23(1):55-59.
    View in: PubMed
    Score: 0.014
  15. Urushiyama H, Jo T, Yasunaga H, Yamauchi Y, Matsui H, Hasegawa W, Takeshima H, Hiraishi Y, Mitani A, Fushimi K, Nagase T. Adjuvant chemotherapy versus chemoradiotherapy for small cell lung cancer with lymph node metastasis: a retrospective observational study with use of a national database in Japan. BMC Cancer. 2017 Sep 02; 17(1):613.
    View in: PubMed
    Score: 0.014
  16. Hasegawa W, Yamauchi Y, Yasunaga H, Takeshima H, Sakamoto Y, Jo T, Sasabuchi Y, Matsui H, Fushimi K, Nagase T. Prognostic nomogram for inpatients with asthma exacerbation. BMC Pulm Med. 2017 Aug 04; 17(1):108.
    View in: PubMed
    Score: 0.014
  17. Sakamoto Y, Yamauchi Y, Yasunaga H, Takeshima H, Hasegawa W, Jo T, Sasabuchi Y, Matsui H, Fushimi K, Nagase T. Development of a nomogram for predicting in-hospital mortality of patients with exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2017; 12:1605-1611.
    View in: PubMed
    Score: 0.014
  18. Nakamoto K, Watanabe M, Sada M, Inui T, Nakamura M, Honda K, Wada H, Mikami Y, Matsuzaki H, Horie M, Noguchi S, Yamauchi Y, Koyama H, Kogane T, Kohyama T, Takizawa H. Serum Reactive Oxygen Metabolite Levels Predict Severe Exacerbations of Asthma. PLoS One. 2016; 11(10):e0164948.
    View in: PubMed
    Score: 0.013
  19. Hasegawa W, Yamauchi Y, Yasunaga H, Sunohara M, Jo T, Matsui H, Fushimi K, Takami K, Nagase T. Clinical features of 280 hospitalized patients with lymphangioleiomyomatosis in Japan. Respirology. 2015 Jan; 20(1):160-5.
    View in: PubMed
    Score: 0.011
  20. Hasegawa W, Yamauchi Y, Yasunaga H, Sunohara M, Jo T, Matsui H, Fushimi K, Takami K, Nagase T. Factors affecting mortality following emergency admission for chronic obstructive pulmonary disease. BMC Pulm Med. 2014 Sep 24; 14:151.
    View in: PubMed
    Score: 0.011
  21. Kudo K, Arioka H, Takeda Y, Shimbo T, Handa S, Kawana A, Kamimura M, Yamauchi Y, Nagase H, Kobayashi N, Manabe T, Kabe J. An early intensive intervention for inducing inactive asthma in adults--a one-year follow-up observation study. Allergol Int. 2011 Dec; 60(4):433-41.
    View in: PubMed
    Score: 0.009
  22. Urushiyama H, Yamauchi Y, Suzuki S, Sunohara M, Kouyama T, Ohishi N, Fukami T, Nakajima J, Ushiku T, Oota S, Fukayama M, Nagase T. [Case of sarcoidosis with squamous cell carcinoma which originated from solitary bronchial papilloma]. Nihon Kokyuki Gakkai Zasshi. 2010 Nov; 48(11):815-20.
    View in: PubMed
    Score: 0.009
  23. Shannon J, Ernst P, Yamauchi Y, Olivenstein R, Lemiere C, Foley S, Cicora L, Ludwig M, Hamid Q, Martin JG. Differences in airway cytokine profile in severe asthma compared to moderate asthma. Chest. 2008 Feb; 133(2):420-6.
    View in: PubMed
    Score: 0.007
  24. Bourbeau J, Christodoulopoulos P, Maltais F, Yamauchi Y, Olivenstein R, Hamid Q. Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial. Thorax. 2007 Nov; 62(11):938-43.
    View in: PubMed
    Score: 0.007
  25. Lemi?re C, Ernst P, Olivenstein R, Yamauchi Y, Govindaraju K, Ludwig MS, Martin JG, Hamid Q. Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes. J Allergy Clin Immunol. 2006 Nov; 118(5):1033-9.
    View in: PubMed
    Score: 0.006
  26. Nagaro T, Amakawa K, Yamauchi Y, Tabo E, Kimura S, Arai T. Percutaneous cervical cordotomy and subarachnoid phenol block using fluoroscopy in pain control of costopleural syndrome. Pain. 1994 Sep; 58(3):325-330.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support